Global Cell and Gene Therapy Manufacturing QC Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing QC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing QC.
The Cell and Gene Therapy Manufacturing QC market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell and Gene Therapy Manufacturing QC market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Manufacturing QC companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing QC companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cell and Gene Therapy Manufacturing QC market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cell and Gene Therapy Manufacturing QC market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Manufacturing QC companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Bio-Techne Corporation
- BioMerieux SA
- Catalent, Inc.
- Charles River Laboratories International Inc.
- Eurofins Scientific SE
- F. Hoffmann-La Roche Ltd
- Intertek Group plc
- Lonza Group AG
- Merck KGaA
- Sartorius AG
- SGS S.A.
- Sistemic Scotland Limited
- Thermo Fisher Scientific Inc.
- Vigene Biosciences, Inc.
- WuXi AppTec
- Safety Testing
- Purity Testing
- Potency Testing
- Identity Testing
- Stability Testing
- Precision Therapy
- Biological Research
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing QC companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2018-2029)
2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Size by Region (2018-2023)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2024-2029)
2.3 Cell and Gene Therapy Manufacturing QC Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing QC Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2018-2023)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2022
3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CELL AND GENE THERAPY MANUFACTURING QC BREAKDOWN DATA BY TYPE
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2018-2023)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2024-2029)
5 CELL AND GENE THERAPY MANUFACTURING QC BREAKDOWN DATA BY APPLICATION
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2018-2023)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Detail
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Detail
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Detail
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Detail
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Detail
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Detail
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Detail
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Detail
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Detail
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Detail
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Detail
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Detail
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Detail
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Detail
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.15.5 WuXi AppTec Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Safety Testing
1.2.3 Purity Testing
1.2.4 Potency Testing
1.2.5 Identity Testing
1.2.6 Stability Testing
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing QC Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Precision Therapy
1.3.3 Biological Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Cell and Gene Therapy Manufacturing QC Market Perspective (2018-2029)
2.2 Cell and Gene Therapy Manufacturing QC Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Manufacturing QC Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cell and Gene Therapy Manufacturing QC Historic Market Size by Region (2018-2023)
2.2.3 Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2024-2029)
2.3 Cell and Gene Therapy Manufacturing QC Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing QC Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing QC Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing QC Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing QC Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing QC Players by Revenue (2018-2023)
3.1.2 Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Manufacturing QC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing QC Revenue
3.4 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing QC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing QC Revenue in 2022
3.5 Cell and Gene Therapy Manufacturing QC Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing QC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CELL AND GENE THERAPY MANUFACTURING QC BREAKDOWN DATA BY TYPE
4.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Type (2018-2023)
4.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2024-2029)
5 CELL AND GENE THERAPY MANUFACTURING QC BREAKDOWN DATA BY APPLICATION
5.1 Global Cell and Gene Therapy Manufacturing QC Historic Market Size by Application (2018-2023)
5.2 Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
6.2 North America Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
6.4 North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
7.2 Europe Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
7.4 Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2018-2023)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
9.2 Latin America Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
9.4 Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Bio-Techne Corporation
11.1.1 Bio-Techne Corporation Company Detail
11.1.2 Bio-Techne Corporation Business Overview
11.1.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Introduction
11.1.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.1.5 Bio-Techne Corporation Recent Development
11.2 BioMerieux SA
11.2.1 BioMerieux SA Company Detail
11.2.2 BioMerieux SA Business Overview
11.2.3 BioMerieux SA Cell and Gene Therapy Manufacturing QC Introduction
11.2.4 BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.2.5 BioMerieux SA Recent Development
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Detail
11.3.2 Catalent, Inc. Business Overview
11.3.3 Catalent, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.3.4 Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.3.5 Catalent, Inc. Recent Development
11.4 Charles River Laboratories International Inc.
11.4.1 Charles River Laboratories International Inc. Company Detail
11.4.2 Charles River Laboratories International Inc. Business Overview
11.4.3 Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.4.4 Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.4.5 Charles River Laboratories International Inc. Recent Development
11.5 Eurofins Scientific SE
11.5.1 Eurofins Scientific SE Company Detail
11.5.2 Eurofins Scientific SE Business Overview
11.5.3 Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Introduction
11.5.4 Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.5.5 Eurofins Scientific SE Recent Development
11.6 F. Hoffmann-La Roche Ltd
11.6.1 F. Hoffmann-La Roche Ltd Company Detail
11.6.2 F. Hoffmann-La Roche Ltd Business Overview
11.6.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Introduction
11.6.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.6.5 F. Hoffmann-La Roche Ltd Recent Development
11.7 Intertek Group plc
11.7.1 Intertek Group plc Company Detail
11.7.2 Intertek Group plc Business Overview
11.7.3 Intertek Group plc Cell and Gene Therapy Manufacturing QC Introduction
11.7.4 Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.7.5 Intertek Group plc Recent Development
11.8 Lonza Group AG
11.8.1 Lonza Group AG Company Detail
11.8.2 Lonza Group AG Business Overview
11.8.3 Lonza Group AG Cell and Gene Therapy Manufacturing QC Introduction
11.8.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.8.5 Lonza Group AG Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Cell and Gene Therapy Manufacturing QC Introduction
11.9.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.9.5 Merck KGaA Recent Development
11.10 Sartorius AG
11.10.1 Sartorius AG Company Detail
11.10.2 Sartorius AG Business Overview
11.10.3 Sartorius AG Cell and Gene Therapy Manufacturing QC Introduction
11.10.4 Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.10.5 Sartorius AG Recent Development
11.11 SGS S.A.
11.11.1 SGS S.A. Company Detail
11.11.2 SGS S.A. Business Overview
11.11.3 SGS S.A. Cell and Gene Therapy Manufacturing QC Introduction
11.11.4 SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.11.5 SGS S.A. Recent Development
11.12 Sistemic Scotland Limited
11.12.1 Sistemic Scotland Limited Company Detail
11.12.2 Sistemic Scotland Limited Business Overview
11.12.3 Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Introduction
11.12.4 Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.12.5 Sistemic Scotland Limited Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Detail
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
11.14 Vigene Biosciences, Inc.
11.14.1 Vigene Biosciences, Inc. Company Detail
11.14.2 Vigene Biosciences, Inc. Business Overview
11.14.3 Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Introduction
11.14.4 Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.14.5 Vigene Biosciences, Inc. Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Detail
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec Cell and Gene Therapy Manufacturing QC Introduction
11.15.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
11.15.5 WuXi AppTec Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Safety Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Stability Testing
Table 7. Global Cell and Gene Therapy Manufacturing QC Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2018-2023)
Table 11. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2024-2029)
Table 13. Cell and Gene Therapy Manufacturing QC Market Trends
Table 14. Cell and Gene Therapy Manufacturing QC Market Drivers
Table 15. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 16. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing QC Market Share by Players (2018-2023)
Table 19. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2022)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing QC Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
Table 24. Date of Enter into Cell and Gene Therapy Manufacturing QC Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2018-2023)
Table 28. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2024-2029)
Table 30. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2018-2023)
Table 32. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2024-2029)
Table 34. North America Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bio-Techne Corporation Company Detail
Table 50. Bio-Techne Corporation Business Overview
Table 51. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product
Table 52. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 53. Bio-Techne Corporation Recent Development
Table 54. BioMerieux SA Company Detail
Table 55. BioMerieux SA Business Overview
Table 56. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product
Table 57. BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 58. BioMerieux SA Recent Development
Table 59. Catalent, Inc. Company Detail
Table 60. Catalent, Inc. Business Overview
Table 61. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 62. Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 63. Catalent, Inc. Recent Development
Table 64. Charles River Laboratories International Inc. Company Detail
Table 65. Charles River Laboratories International Inc. Business Overview
Table 66. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product
Table 67. Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 68. Charles River Laboratories International Inc. Recent Development
Table 69. Eurofins Scientific SE Company Detail
Table 70. Eurofins Scientific SE Business Overview
Table 71. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product
Table 72. Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 73. Eurofins Scientific SE Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Detail
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Intertek Group plc Company Detail
Table 80. Intertek Group plc Business Overview
Table 81. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product
Table 82. Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 83. Intertek Group plc Recent Development
Table 84. Lonza Group AG Company Detail
Table 85. Lonza Group AG Business Overview
Table 86. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product
Table 87. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 88. Lonza Group AG Recent Development
Table 89. Merck KGaA Company Detail
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Cell and Gene Therapy Manufacturing QC Product
Table 92. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Sartorius AG Company Detail
Table 95. Sartorius AG Business Overview
Table 96. Sartorius AG Cell and Gene Therapy Manufacturing QC Product
Table 97. Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 98. Sartorius AG Recent Development
Table 99. SGS S.A. Company Detail
Table 100. SGS S.A. Business Overview
Table 101. SGS S.A. Cell and Gene Therapy Manufacturing QC Product
Table 102. SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 103. SGS S.A. Recent Development
Table 104. Sistemic Scotland Limited Company Detail
Table 105. Sistemic Scotland Limited Business Overview
Table 106. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product
Table 107. Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 108. Sistemic Scotland Limited Recent Development
Table 109. Thermo Fisher Scientific Inc. Company Detail
Table 110. Thermo Fisher Scientific Inc. Business Overview
Table 111. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product
Table 112. Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 113. Thermo Fisher Scientific Inc. Recent Development
Table 114. Vigene Biosciences, Inc. Company Detail
Table 115. Vigene Biosciences, Inc. Business Overview
Table 116. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 117. Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 118. Vigene Biosciences, Inc. Recent Development
Table 119. WuXi AppTec Company Detail
Table 120. WuXi AppTec Business Overview
Table 121. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product
Table 122. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 123. WuXi AppTec Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 1. Global Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Safety Testing
Table 3. Key Players of Purity Testing
Table 4. Key Players of Potency Testing
Table 5. Key Players of Identity Testing
Table 6. Key Players of Stability Testing
Table 7. Global Cell and Gene Therapy Manufacturing QC Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Cell and Gene Therapy Manufacturing QC Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2018-2023)
Table 11. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Cell and Gene Therapy Manufacturing QC Market Share by Region (2024-2029)
Table 13. Cell and Gene Therapy Manufacturing QC Market Trends
Table 14. Cell and Gene Therapy Manufacturing QC Market Drivers
Table 15. Cell and Gene Therapy Manufacturing QC Market Challenges
Table 16. Cell and Gene Therapy Manufacturing QC Market Restraints
Table 17. Global Cell and Gene Therapy Manufacturing QC Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Cell and Gene Therapy Manufacturing QC Market Share by Players (2018-2023)
Table 19. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2022)
Table 20. Ranking of Global Top Cell and Gene Therapy Manufacturing QC Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cell and Gene Therapy Manufacturing QC Product Solution and Service
Table 24. Date of Enter into Cell and Gene Therapy Manufacturing QC Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cell and Gene Therapy Manufacturing QC Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2018-2023)
Table 28. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Type (2024-2029)
Table 30. Global Cell and Gene Therapy Manufacturing QC Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2018-2023)
Table 32. Global Cell and Gene Therapy Manufacturing QC Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Cell and Gene Therapy Manufacturing QC Revenue Market Share by Application (2024-2029)
Table 34. North America Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bio-Techne Corporation Company Detail
Table 50. Bio-Techne Corporation Business Overview
Table 51. Bio-Techne Corporation Cell and Gene Therapy Manufacturing QC Product
Table 52. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 53. Bio-Techne Corporation Recent Development
Table 54. BioMerieux SA Company Detail
Table 55. BioMerieux SA Business Overview
Table 56. BioMerieux SA Cell and Gene Therapy Manufacturing QC Product
Table 57. BioMerieux SA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 58. BioMerieux SA Recent Development
Table 59. Catalent, Inc. Company Detail
Table 60. Catalent, Inc. Business Overview
Table 61. Catalent, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 62. Catalent, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 63. Catalent, Inc. Recent Development
Table 64. Charles River Laboratories International Inc. Company Detail
Table 65. Charles River Laboratories International Inc. Business Overview
Table 66. Charles River Laboratories International Inc. Cell and Gene Therapy Manufacturing QC Product
Table 67. Charles River Laboratories International Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 68. Charles River Laboratories International Inc. Recent Development
Table 69. Eurofins Scientific SE Company Detail
Table 70. Eurofins Scientific SE Business Overview
Table 71. Eurofins Scientific SE Cell and Gene Therapy Manufacturing QC Product
Table 72. Eurofins Scientific SE Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 73. Eurofins Scientific SE Recent Development
Table 74. F. Hoffmann-La Roche Ltd Company Detail
Table 75. F. Hoffmann-La Roche Ltd Business Overview
Table 76. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing QC Product
Table 77. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 78. F. Hoffmann-La Roche Ltd Recent Development
Table 79. Intertek Group plc Company Detail
Table 80. Intertek Group plc Business Overview
Table 81. Intertek Group plc Cell and Gene Therapy Manufacturing QC Product
Table 82. Intertek Group plc Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 83. Intertek Group plc Recent Development
Table 84. Lonza Group AG Company Detail
Table 85. Lonza Group AG Business Overview
Table 86. Lonza Group AG Cell and Gene Therapy Manufacturing QC Product
Table 87. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 88. Lonza Group AG Recent Development
Table 89. Merck KGaA Company Detail
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Cell and Gene Therapy Manufacturing QC Product
Table 92. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Sartorius AG Company Detail
Table 95. Sartorius AG Business Overview
Table 96. Sartorius AG Cell and Gene Therapy Manufacturing QC Product
Table 97. Sartorius AG Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 98. Sartorius AG Recent Development
Table 99. SGS S.A. Company Detail
Table 100. SGS S.A. Business Overview
Table 101. SGS S.A. Cell and Gene Therapy Manufacturing QC Product
Table 102. SGS S.A. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 103. SGS S.A. Recent Development
Table 104. Sistemic Scotland Limited Company Detail
Table 105. Sistemic Scotland Limited Business Overview
Table 106. Sistemic Scotland Limited Cell and Gene Therapy Manufacturing QC Product
Table 107. Sistemic Scotland Limited Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 108. Sistemic Scotland Limited Recent Development
Table 109. Thermo Fisher Scientific Inc. Company Detail
Table 110. Thermo Fisher Scientific Inc. Business Overview
Table 111. Thermo Fisher Scientific Inc. Cell and Gene Therapy Manufacturing QC Product
Table 112. Thermo Fisher Scientific Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 113. Thermo Fisher Scientific Inc. Recent Development
Table 114. Vigene Biosciences, Inc. Company Detail
Table 115. Vigene Biosciences, Inc. Business Overview
Table 116. Vigene Biosciences, Inc. Cell and Gene Therapy Manufacturing QC Product
Table 117. Vigene Biosciences, Inc. Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 118. Vigene Biosciences, Inc. Recent Development
Table 119. WuXi AppTec Company Detail
Table 120. WuXi AppTec Business Overview
Table 121. WuXi AppTec Cell and Gene Therapy Manufacturing QC Product
Table 122. WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing QC Business (2018-2023) & (US$ Million)
Table 123. WuXi AppTec Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cell and Gene Therapy Manufacturing QC Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell and Gene Therapy Manufacturing QC Market Share by Type: 2022 VS 2029
Figure 3. Safety Testing Features
Figure 4. Purity Testing Features
Figure 5. Potency Testing Features
Figure 6. Identity Testing Features
Figure 7. Stability Testing Features
Figure 8. Global Cell and Gene Therapy Manufacturing QC Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2022 VS 2029
Figure 10. Precision Therapy Case Studies
Figure 11. Biological Research Case Studies
Figure 12. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cell and Gene Therapy Manufacturing QC Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cell and Gene Therapy Manufacturing QC Market Share by Region: 2022 VS 2029
Figure 16. Global Cell and Gene Therapy Manufacturing QC Market Share by Players in 2022
Figure 17. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2022
Figure 19. North America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 21. United States Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 25. Germany Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Region (2018-2029)
Figure 33. China Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 41. Mexico Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 45. Turkey Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 48. BioMerieux SA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 49. Catalent, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 50. Charles River Laboratories International Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 51. Eurofins Scientific SE Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 53. Intertek Group plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 54. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 55. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 56. Sartorius AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 57. SGS S.A. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 58. Sistemic Scotland Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 60. Vigene Biosciences, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 61. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Global Cell and Gene Therapy Manufacturing QC Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cell and Gene Therapy Manufacturing QC Market Share by Type: 2022 VS 2029
Figure 3. Safety Testing Features
Figure 4. Purity Testing Features
Figure 5. Potency Testing Features
Figure 6. Identity Testing Features
Figure 7. Stability Testing Features
Figure 8. Global Cell and Gene Therapy Manufacturing QC Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Cell and Gene Therapy Manufacturing QC Market Share by Application: 2022 VS 2029
Figure 10. Precision Therapy Case Studies
Figure 11. Biological Research Case Studies
Figure 12. Cell and Gene Therapy Manufacturing QC Report Years Considered
Figure 13. Global Cell and Gene Therapy Manufacturing QC Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Cell and Gene Therapy Manufacturing QC Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Cell and Gene Therapy Manufacturing QC Market Share by Region: 2022 VS 2029
Figure 16. Global Cell and Gene Therapy Manufacturing QC Market Share by Players in 2022
Figure 17. Global Top Cell and Gene Therapy Manufacturing QC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing QC as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Manufacturing QC Revenue in 2022
Figure 19. North America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 21. United States Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 25. Germany Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Share by Region (2018-2029)
Figure 33. China Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 41. Mexico Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing QC Market Share by Country (2018-2029)
Figure 45. Turkey Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Cell and Gene Therapy Manufacturing QC Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 48. BioMerieux SA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 49. Catalent, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 50. Charles River Laboratories International Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 51. Eurofins Scientific SE Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 53. Intertek Group plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 54. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 55. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 56. Sartorius AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 57. SGS S.A. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 58. Sistemic Scotland Limited Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 60. Vigene Biosciences, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 61. WuXi AppTec Revenue Growth Rate in Cell and Gene Therapy Manufacturing QC Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
